Trials / Conditions / Autoimmune Thrombocytopenic Purpura
Autoimmune Thrombocytopenic Purpura
5 registered clinical trials studyying Autoimmune Thrombocytopenic Purpura.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disord NCT01610180 | Fondazione Progetto Ematologia | Phase 2 |
| Terminated | Study of Veltuzumab (hA20) at Different Doses in Patients With ITP NCT00547066 | Gilead Sciences | Phase 1 / Phase 2 |
| Terminated | Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and NCT00225875 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Unknown | Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura NCT00107913 | Hematology and Oncology Specialists | Phase 2 |
| Unknown | Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases NCT00006055 | Fairview University Medical Center | N/A |